Evidence map›Paper›PMID 29206031›Full record

ArticleJournal of the American Chemical Society2017

Chemoselective Installation of Amine Bonds on Proteins through Aza-Michael Ligation.

Allyson M Freedy, Maria J Matos, Omar Boutureira, Francisco Corzana, Ana Guerreiro, Padma Akkapeddi, Víctor J Somovilla, Tiago Rodrigues, Karl Nicholls, Bangwen Xie and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Article
  3. Manganese-Catalyzed Electrochemical Diazidation of Dehydroalanine Peptides.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  4. Late-Stage Amination of Peptides on the Solid Phase.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  5. Article
  6. Poly-Dha Sequences asJACS Au · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Novel [EJNMMI radiopharmacy and chemistry · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Allyson M FreedyDepartment of Chemistry, University of Cambridge , Lensfield Road, CB2 1EW Cambridge, U.K.
Maria J MatosDepartment of Chemistry, University of Cambridge , Lensfield Road, CB2 1EW Cambridge, U.K.
Omar BoutureiraDepartment of Chemistry, University of Cambridge , Lensfield Road, CB2 1EW Cambridge, U.K.ORCID 0000-0002-0768-8309
Francisco CorzanaDepartment of Chemistry, University of Cambridge , Lensfield Road, CB2 1EW Cambridge, U.K.ORCID 0000-0001-5597-8127
Ana GuerreiroInstituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa , Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.
Padma AkkapeddiInstituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa , Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.
Víctor J SomovillaDepartment of Chemistry, University of Cambridge , Lensfield Road, CB2 1EW Cambridge, U.K.
Tiago RodriguesInstituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa , Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.
Karl NichollsAlbumedix Ltd., Castle Court , 59 Castle Boulevard, NG7 1FD Nottingham, U.K.
Bangwen XieLi Ka Shing Centre, Cancer Research UK Cambridge Institute , Robinson Way, CB2 0RE Cambridge, U.K.
Gonzalo Jiménez-OsésDepartamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja , 26006 Logroño, Spain.ORCID 0000-0003-0105-4337
Kevin M BrindleDepartamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja , 26006 Logroño, Spain.
André A NevesLi Ka Shing Centre, Cancer Research UK Cambridge Institute , Robinson Way, CB2 0RE Cambridge, U.K.
Gonçalo J L BernardesDepartment of Chemistry, University of Cambridge , Lensfield Road, CB2 1EW Cambridge, U.K.ORCID 0000-0001-6594-8917
Universidad de La Rioja · ESUniversity of Lisbon · PTUniversity of Cambridge · GBCancer Research UK · GBAlbumedix (United Kingdom) · GB

Funding

Cancer Research UK 17242
6 · The paper itself

Abstract

Chemical modification of proteins is essential for a variety of important diagnostic and therapeutic applications. Many strategies developed to date lack chemo- and regioselectivity as well as result in non-native linkages that may suffer from instability in vivo and adversely affect the protein's structure and function. We describe here the reaction of N-nucleophiles with the amino acid dehydroalanine (Dha) in a protein context. When Dha is chemically installed in proteins, the addition of a wide-range N-nucleophiles enables the rapid formation of amine linkages (secondary and tertiary) in a chemoselective manner under mild, biocompatible conditions. These new linkages are stable at a wide range of pH values (pH 2.8 to 12.8), under reducing conditions (biological thiols such as glutathione) and in human plasma. This method is demonstrated for three proteins and is shown to be fully compatible with disulfide bridges, as evidenced by the selective modification of recombinant albumin that displays 17 structurally relevant disulfides. The practicability and utility of our approach is further demonstrated by the construction of a chemically modified C2A domain of Synaptotagmin-I protein that retains its ability to preferentially bind to apoptotic cells at a level comparable to the native protein. Importantly, the method was useful for building a homogeneous antibody-drug conjugate with a precise drug-to-antibody ratio of 2. The kinase inhibitor crizotinib was directly conjugated to Dha through its piperidine motif, and its antibody-mediated intracellular delivery results in 10-fold improvement of its cancer cell-killing efficacy. The simplicity and exquisite site-selectivity of the aza-Michael ligation described herein allows the construction of stable secondary and tertiary amine-linked protein conjugates without affecting the structure and function of biologically relevant proteins.

Indexed as

AlanineAlbuminsAminesAnimalsAnnexin A5AntibodiesCell DeathCell Line, TumorCell SurvivalCrizotinibDisulfidesDose-Response Relationship, DrugHEK293 CellsHumansKineticsMiceAlanineAlbuminsAminesAnnexin A5AntibodiesCrizotinibdehydroalanineDisulfidesPyrazolesPyridinesSynaptotagmin I

Identifiers

PMID29206031
PMCPMC5799870
OpenAlexW2774844634

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.